FDA Inspection 1024147 — Nanjing Xingyin Pharmaceutical Group Co. Ltd.
The FDA completed an inspection of Nanjing Xingyin Pharmaceutical Group Co. Ltd. on August 31, 2017 in Nanjing. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 31, 2017
- Fiscal Year
- 2017
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Nanjing (China)